IMMUNOGEN INC IMGN (NASDAQ)

$ 5.20
19:09
Change: +0.34 (+7.00%)
Volume: 405,700

Avg. Volume: 174755
P/E Ratio: 0
EPS (Annual): -0.74
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 42,910
Institutional Shareholders: 35.05%
Last: 5.20
Change: +0.34 (+7.00%)
Prev. Close: 4.86
Open: 4.84
Day's Range: 4.58 - 5.25
52wk Range: 2.64 - 5.80
Market Value: 246,780
Beta: 2.54
12-month EPS Change: 0.00%
Total Return Last 12 Months: +0.97%
Total Return Last 3 Years: -31.84%
Total Return Last 5 Years: +10.17%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on IMGN

ImmunoGen names Junius president, COO

(CAMBRIDGE, Mass.)Biotechnology company ImmunoGen Inc. said Thursday it promoted Daniel M. Junius to the new position of president and chief operating officer. Junius, 55, has been an executive vice...READ MORE
Jul 31, 2008 7:41AM
Keywords: IMGN

Sector Wrap: Celgene, Genentech in ASCO spotlight

(NEW YORK)Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June ...READ MORE
May 16, 2008 4:04PM
Keywords: CELG, DNA, IMCL, AMGN, ARIA, CGRB, EXEL, GENZ, IMGN, OSIP, PARD

Immunogen Stock Rises on Drug Filing

(NEW YORK)Immunogen and Biotest are asking for government approval of a new cancer-fighting drug. The drug, called BT-062, is said to be able to stick to certain kinds of cancer cells and de...READ MORE
Mar 12, 2008 1:51PM
Keywords: IMGN

ImmunoGen to Receive Biogen Payment

(CAMBRIDGE, Mass.)ImmunoGen Inc. said Friday it will receive a $1.5 million payment after its partner Biogen Idec Inc. asked the Food and Drug Administration to approve studies on an experimental an...READ MORE
Feb 01, 2008 10:51AM
Keywords: IMGN, BIIB

ImmunoGen Licenses J&J Cancer Compound

(CAMBRIDGE, Mass.)Biotechnology company ImmunoGen Inc. said Thursday it licensed an experimental cancer treatment from Johnson & Johnson's Centocor unit. Under the deal, ImmunoGen gains the exclusiv...READ MORE
Jan 03, 2008 10:51AM
Keywords: IMGN, JNJ

Sector Snap: Biotech Attractive in 2008

(NEW YORK)Lazard Capital Markets said Wednesday rising demand for new medical treatments will continue to drive earnings growth in the biotechnology sector in 2008, providing attractive oppo...READ MORE
Jan 02, 2008 2:30PM
Keywords: AMGN, DNA, CELG, GILD, ACOR, PDLI, BIIB, OSIR, VRTX, IMGN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -19.50 18.51
MERCK CO INC -32.20 34.30
JOHNSON AND JOH +18.40 70.67
SCHERING PLOUGH -28.80 19.26
BRISTOL MYERS S -18.00 21.49